Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 10 » Issue 1

COPD: it is time to change!

Authors Tantucci C, Pini L

Received 30 April 2015

Accepted for publication 23 June 2015

Published 11 November 2015 Volume 2015:10(1) Pages 2451—2457


Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Professor Hsiao-Chi Chuang

Peer reviewer comments 3

Editor who approved publication: Dr Richard Russell

Claudio Tantucci, Laura Pini

Respiratory Medicine Unit, Department of Experimental and Clinical Sciences, University of Brescia, Brescia, Italy

Abstract: COPD is a common cause of disability, morbidity and mortality worldwide and a major global health problem with enormous direct and indirect health care costs. Different reasons can be advanced to explain it, but among them the possibility that the recommended diagnostic and therapeutic approaches to COPD were less effective than they could be, should be also considered. The pharmacological baseline treatment of stable COPD has been widely based on the severity of airflow obstruction and recently, of chronic symptoms and on the annual number of previous exacerbations. These recommendations do not take into account the underlying prevalent disease that should be treated and the future risk. Our suggestion is that the therapy must be firstly tailored on the prevalent disease leading to COPD, independently from the degree of FEV1 reduction and chronic dyspnea and only after that, according to the severity of the disorder (and age of patient), to establish the level of the treatment in order to freeze, when possible, and not to follow the underlying pathological process, running after it. Moreover, given the relevance of exacerbations in the natural history of COPD, greater effort should be placed on recognition of their prevalent type in frequent exacerbators and to prevent them using more tailored and specific treatment.

Keywords: COPD, therapeutic approach of COPD, prevention of COPD exacerbations

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]


Readers of this article also read:

Computed tomography measurement of pulmonary artery for diagnosis of COPD and its comorbidity pulmonary hypertension

Chen X, Liu K, Wang Z, Zhu Y, Zhao Y, Kong H, Xie W, Wang H

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2525-2533

Published Date: 18 November 2015

COPD in Taiwan: a National Epidemiology Survey

Cheng SL, Chan MC, Wang CC, Lin CH, Wang HC, Hsu JY, Hang LW, Chang CJ, Perng DW, Yu CJ

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2459-2467

Published Date: 11 November 2015

The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia

Duman D, Aksoy E, Agca MC, Kocak ND, Ozmen I, Akturk UA, Gungor S, Tepetam FM, Eroglu SA, Oztas S, Karakurt Z

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2469-2478

Published Date: 11 November 2015

Pulmonary hemodynamic profile in chronic obstructive pulmonary disease [Corrigendum]

Portillo K, Torralba Y, Blanco I, Burgos F, Rodriguez-Roisin R, Rios J, Roca J, Barberà JA

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2377-2378

Published Date: 4 November 2015

Prevalence of chronic obstructive pulmonary disease in asymptomatic smokers

Sansores RH, Velázquez-Uncal M, Pérez-Bautista O, Villalba-Caloca J, Falfán-Valencia R, Ramírez-Venegas A

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2357-2363

Published Date: 2 November 2015

The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients

Darbà J, Ramírez G, Sicras A, Francoli P, Torvinen S, Sánchez-de la Rosa R

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2335-2345

Published Date: 29 October 2015